Alerts will be sent to your verified email
Verify EmailMANGALAM
Mangalam Drugs&Org.
|
Brooks Laboratories
|
Ambalal Sarabhai Ent
|
|
---|---|---|---|
Operational Metrics
|
|||
Unclassified
|
|||
Advertisement Spend as a % of Total Sales
|
0.37 % | n/a | n/a |
R&D as a % of Total Sales
|
0.0 | n/a | 0.06 % |
Financials
|
|||
5 yr Average ROE
|
6.95 % | -21.88 % | 26.58 % |
5yr average Equity Multiplier
|
2.2 | 1.92 | 3.52 |
5yr Average Asset Turnover Ratio
|
1.23 | 0.51 | 0.76 |
5yr Avg Net Profit Margin
|
2.26 % | -23.51 % | 12.36 % |
Price to Book
|
1.16 | 3.54 | 2.9 |
P/E
|
0.0 | 0.0 | 127.85 |
5yr Avg Cash Conversion Cycle
|
60.01 Days | 14.66 Days | -57.89 Days |
Inventory Days
|
85.85 Days | 108.65 Days | 34.77 Days |
Days Receivable
|
45.61 Days | 87.83 Days | 57.49 Days |
Days Payable
|
78.22 Days | 198.03 Days | 157.48 Days |
5yr Average Interest Coverage Ratio
|
2.37 | -8.4 | 10.7 |
5yr Avg ROCE
|
14.99 % | -21.22 % | 32.34 % |
5yr Avg Operating Profit Margin
|
9.23 % | -18.2 % | 17.75 % |
5 yr average Debt to Equity
|
0.53 | 0.25 | 0.58 |
5yr CAGR Net Profit
|
n/a | 1.52 % | 21.17 % |
5yr Average Return on Assets
|
3.33 % | -12.27 % | 9.78 % |
Shareholdings
|
|||
Promoter Holding
|
50.32 % | 63.59 % | 30.77 % |
Share Pledged by Promoters
|
17.58 % | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-0.21 % | -2.82 % | 0.01 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 3.86 % | 0.0 |
Mangalam Drugs&Org.
|
Brooks Laboratories
|
Ambalal Sarabhai Ent
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
Location Wise Break-Up
|
Raw Material Break-Up
|
Raw Material Break-Up
|
-
|
-
|